CONCLUSIONS: Evidence remains limited by methodological heterogeneity, small samples, variable controls, inconsistent learning metrics, and risk of bias. Current RCTs do not demonstrate evidence of efficacy over placebo. Blinded, adequately powered trials using standardised learning measures are needed to clarify mechanisms of neurofeedback.
